Evaluation of GS Junior and MiSeq next-generation sequencing technologies as an alternative to Trugene population sequencing in the clinical HIV laboratory

Archer, 2012, Analysis of high-depth sequence data for studying viral diversity: a comparison of next generation sequencing platforms using Segminator II, BMC Bioinform., 13, 47, 10.1186/1471-2105-13-47 Archer, 2012, Use of four next-generation sequencing platforms to determine HIV-1 coreceptor tropism, PLoS ONE, 7, e49602, 10.1371/journal.pone.0049602 Armenia, 2012, Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencing, J. Infect. Dis., 205, 557, 10.1093/infdis/jir821 Avidor, 2013, Evaluation of a benchtop HIV ultradeep pyrosequencing drug resistance assay in the clinical laboratory, J. Clin. Microbiol., 51, 880, 10.1128/JCM.02652-12 Beerenwinkel, 2012, Challenges and opportunities in estimating viral genetic diversity from next-generation sequencing data, Front. Microbiol., 3, 329, 10.3389/fmicb.2012.00329 Buzon, 2011, Deep molecular characterization of HIV-1 dynamics under suppressive HAART, PLoS Pathog., 7, e1002314, 10.1371/journal.ppat.1002314 Codoner, 2011, Added value of deep sequencing relative to population sequencing in heavily pre-treated HIV-1-infected subjects, PLoS ONE, 6, e19461, 10.1371/journal.pone.0019461 D’Aquila, 2011, Tenofovir (TDF)-selected or abacavir (ABC)-selected low-frequency HIV type 1 subpopulations during failure with persistent viremia as detected by ultradeep pyrosequencing, AIDS Res. Hum. Retroviruses, 27, 201, 10.1089/aid.2010.0077 Dudley, 2012, Low-cost ultra-wide genotyping using Roche/454 pyrosequencing for surveillance of HIV drug resistance, PLoS ONE, 7, e36494, 10.1371/journal.pone.0036494 Dundas, 2008, Comparison of automated nucleic acid extraction methods with manual extraction, J. Mol. Diagn., 10, 311, 10.2353/jmoldx.2008.070149 Fisher, 2012, Deep sequencing reveals minor protease resistance mutations in patients failing a protease inhibitor regimen, J. Virol., 86, 6231, 10.1128/JVI.06541-11 Gall, 2012, Universal amplification, next-generation sequencing, and assembly of HIV-1 genomes, J. Clin. Microbiol., 50, 3838, 10.1128/JCM.01516-12 Gianella, 2010, Minority variants of drug-resistant HIV, J. Infect. Dis., 202, 657, 10.1086/655397 Glenn, 2011, Field guide to next-generation DNA sequencers, Mol. Ecol. Resour., 11, 759, 10.1111/j.1755-0998.2011.03024.x Halvas, 2006, Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency, J. Clin. Microbiol., 44, 2612, 10.1128/JCM.00449-06 Hedskog, 2010, Dynamics of HIV-1 quasispecies during antiviral treatment dissected using ultra-deep pyrosequencing, PLoS ONE, 5, e11345, 10.1371/journal.pone.0011345 Jiang, 2012, Rapid and efficient human mutation detection using a bench-top next-generation DNA sequencer, Hum. Mutat., 33, 281, 10.1002/humu.21602 Joshi, 2011, Sickle: a sliding-window, adaptive, quality-based trimming tool for FastQ files (Version 1.33) [Software] Kivioja, 2011, Counting absolute numbers of molecules using unique molecular identifiers, Nat. Methods, 9, 72, 10.1038/nmeth.1778 Le, 2009, Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral use, PLoS ONE, 4, e6079, 10.1371/journal.pone.0006079 Li, 2010, Fast and accurate long-read alignment with Burrows–Wheeler transform, Bioinformatics, 26, 589, 10.1093/bioinformatics/btp698 Li, 2009, The sequence alignment/map format and SAMtools, Bioinformatics, 25, 2078, 10.1093/bioinformatics/btp352 Li, 2014, Comparison of illumina and 454 deep sequencing in participants failing raltegravir-based antiretroviral therapy, PLoS ONE, 9, e90485, 10.1371/journal.pone.0090485 Messiaen, 2012, Ultra-deep sequencing of HIV-1 reverse transcriptase before start of an NNRTI-based regimen in treatment-naive patients, Virology, 426, 7, 10.1016/j.virol.2012.01.002 Paredes, 2012, Use of DeepChek-HIV system in the PRIUS study: validation of a new reliable genotyping solution to streamline the 454 sequencing analysis of HIV drug resistance in routine diagnosis and research applications, Antivir. Ther., 17, A151 Pou, 2014, Improved prediction of salvage antiretroviral therapy outcomes using ultrasensitive HIV-1 drug resistance testing, Clin. Infect. Dis., 10.1093/cid/ciu287 Schuurman, 2002, Underestimation of HIV type 1 drug resistance mutations: results from the ENVA-2 genotyping proficiency program, AIDS Res. Hum. Retroviruses, 18, 243, 10.1089/088922202753472801 Shafer, 2006, Rationale and uses of a public HIV drug-resistance database, J. Infect. Dis., 194, S51L 8 Shendure, 2012, The expanding scope of DNA sequencing, Nat. Biotechnol., 30, 1084, 10.1038/nbt.2421 Shulman, 2012, Evaluation of four different systems for extraction of RNA from stool suspensions using MS-2 coliphage as an exogenous control for RT-PCR inhibition, PLoS ONE, 7, e39455, 10.1371/journal.pone.0039455 Simen, 2014, An international multicenter study on HIV-1 drug resistance testing by 454 ultra-deep pyrosequencing, J. Virol. Methods, 204, 31, 10.1016/j.jviromet.2014.04.007 Simen, 2009, Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes, J. Infect. Dis., 199, 693, 10.1086/596736 Snoeck, 2005, Optimization of a genotypic assay applicable to all human immunodeficiency virus type 1 protease and reverse transcriptase subtypes, J. Virol. Methods, 128, 47, 10.1016/j.jviromet.2005.04.001 Stelzl, 2011, Human immunodeficiency virus type 1 drug resistance testing: evaluation of a new ultra-deep sequencing-based protocol and comparison with the TRUGENE HIV-1 Genotyping Kit, J. Virol. Methods, 178, 94, 10.1016/j.jviromet.2011.08.020 Zagordi, 2010, Error correction of next-generation sequencing data and reliable estimation of HIV quasispecies, Nucleic Acids Res., 38, 7400, 10.1093/nar/gkq655 Zhou, 2011, Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings, PLoS ONE, 6, e28184, 10.1371/journal.pone.0028184